A CASE OF MALIGNANT HEMANGIOENDOTHELIOMA SHOWING RESPONSE TO INTERLEUKIN 2 THERAPY

被引：11

作者：

INADOMI, T

FUJIOKA, A

SUZUKI, H

机构：

来源：

BRITISH JOURNAL OF DERMATOLOGY | 1992年 / 127卷 / 04期

关键词：

D O I：

10.1111/j.1365-2133.1992.tb00467.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：442 / 443

页数：2

共 9 条

[1]

FUJIOKA A, 1991, JPN J DERMATOL, V101, P959

[2] PRESENCE OF IMMUNOSUPPRESSIVE FACTORS IN BRAIN-TUMOR CYST FLUID [J].

KIKUCHI, K ;

NEUWELT, EA .

JOURNAL OF NEUROSURGERY, 1983, 59 (05) :790-799

[3] NEUROENDOCRINE EFFECTS OF SUBCUTANEOUS INTERLEUKIN-2 INJECTION IN CANCER-PATIENTS [J].

LISSONI, P ;

BARNI, S ;

ROVELLI, F ;

CRISPINO, S ;

FUMAGALLI, G ;

PESCIA, S ;

VAGHI, M ;

CAMESASCA, G ;

TANCINI, G .

TUMORI, 1991, 77 (03) :212-215

[4]

MACKIE RM, 1992, TXB DERMATOLOGY, V3, P2091

[5]

Masuzawa M., 1988, JPN J DERMATOL, V98, P367

[6] IMMUNOTHERAPY WITH IL2 BY CONSTANT INFUSION AND WEEKLY DOXORUBICIN [J].

PACIUCCI, PA ;

BEKESI, JG ;

RYDER, JS ;

ODCHIMAR, R ;

CHAHINIAN, PA ;

HOLLAND, JF .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1991, 14 (04) :341-348

[7]

ROTH JA, 1982, J IMMUNOL, V128, P1955

[8] IMMUNOPATHOLOGICAL FEATURES OF HUMAN PULMONARY TUMORS FOLLOWING LOW-DOSE INTERLEUKIN-2 [J].

SWISHER, SG ;

ANDERSON, TM ;

WEN, DR ;

STENE, MA ;

COCHRAN, AJ ;

GOLUB, SH ;

HOLMES, EC .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 1991, 33 (05) :327-332

[9] PHASE-II STUDY OF INTRAVENOUS BOLUS RECOMBINANT INTERLEUKIN-2 IN ADVANCED MALIGNANT-MELANOMA - SOUTHWEST ONCOLOGY GROUP-STUDY [J].

WHITEHEAD, RP ;

KOPECKY, KJ ;

SAMSON, MK ;

COSTANZI, JJ ;

NATALE, RB ;

FEUN, LG ;

HERSH, EM ;

RINEHART, JJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (17) :1250-1252

← 1 →